ATAI Life Sciences, a biopharmaceutical company, announced that it will adopt a bitcoin financial strategy and plans to invest an initial $5 million in bitcoin. Affected by the news, ATAI's share price briefly rose. Christian Angermayer, chairperson of the company, said that the company plans to invest an initial $5 million in bitcoin, while retaining sufficient cash, short-term securities and public equity to protect the company's operating funds until 2027.